Mohsan Ali, MBBS

Current evidence underscores the potential of GLP-1 receptor agonists as a novel therapeutic approach for certain psychiatric disorders, particularly AUDs, depression, and autism-related food behaviors.

The authors provide a bibliometric analysis of the most-cited articles published from 1990 to 2020 on evidence-based treatment modalities for PTSD to highlight significant developments in its understanding and management.

The authors examined NIH funding patterns in the distribution of R01 grants for gender-specific psychiatry research.

In 1999, about 150,000 Americans died from dementia. By 2020, that number had tripled to over 450,000, with both men and women across various ethnicities affected. Nonmetropolitan areas saw...